Thornwood, NY—Carl Zeiss AG announced changes to its executive board, effective January 1, 2014. Headed by Dr. Michael Kaschke, president and CEO, the board will be enlarged and there will be a reallocation of responsibilities aimed at strengthening Zeiss’s market position and leveraging the synergy among its business groups through shared services and corporate functions. It was also announced that Thomas Spitzenpfeil, CFO, will assume responsibility for the Camera Lenses group.
The supervisory board of Carl Zeiss AG renewed the contract of executive board member and head of the Semiconductor Manufacturing Technology business group (SMT), Dr. Hermann Gerlinger, until September 30, 2017. Dr. Gerlinger has headed the SMT since 2001 and has been an executive board member since October 2006.
Also, a new member will join Carl Zeiss AG’s executive board, effective January 1, 2014. Dr. Ludwin Monz, head of the Medical Technology business group and president and CEO of the subsidiary Carl Zeiss Meditec AG, will become the fourth member of the board. Dr. Monz has headed the Medical Technology group since March 2010 and will continue to be responsible for this area and its operational management on the executive board. His appointment to the executive board is also effective until September 30, 2017. Monz will continue to be based at the Jena site, the headquarters of Carl Zeiss Meditec AG.
“The executive board consists of members with a broad spectrum of experience who have a close bond with Zeiss,” said Dr. Dieter Kurz, chairman of the supervisory board of Carl Zeiss AG. “The renewal of Dr. Gerlinger's contract and the new appointment of Dr. Monz sharpen the focus on the Zeiss growth markets and intensify the closeness of top management to the different customers and markets. This lays a solid foundation for the further positive development of the Zeiss Group.”
In addition to the enlargement of the executive board, there will be a realignment of responsibilities within the board, effective January 1, 2014, with the goal of combining business activities, functions and markets as stringently as possible according to focal areas of responsibility, synergy potentials and strategic orientation. This is part of strategy in to keep the Zeiss Group consistently on track for growth.
Dr. Kaschke will oversee Microscopy and Industrial Metrology, the two business groups that operate in the research and quality management markets. Thomas Spitzenpfeil, who will continue in his role of CFO, will assume responsibility for all units focused on consumer markets: Vision Care, Camera Lenses, Planetariums and Sport Optics. zeiss.com